Patritumab deruxtecan in HR+HER2− advanced breast cancer: a phase 2 trial

Journal:
Nature Medicine
Published:
Affiliations:
27
Authors:
46
Institutions Authors Share
National PRecISion Medicine Center in Oncology (IHU Prism), France
7.416667
0.16
Institute Gustave-Roussy (IGR), France
7.166667
0.16
Daiichi Sankyo US, United States of America (USA)
5.000000
0.11
Molecular Predictors and New Targets in Oncology, France
3.583333
0.08
Analyse Moléculaire, Modélisation et Imagerie de la Maladie Cancéreuse (AMMICA), France
3.166667
0.07
Dynamique des cellules tumorales, France
2.333333
0.05
Integrative Tumor Immunology and Genetic Oncology, France
2.000000
0.04
Centre for Research in Epidemiology and Population Health (CESP), France
1.666667
0.04
CentraleSupélec, France
1.583333
0.03
National Institute for Research in Computer Science and Control (INRIA), France
1.083333
0.02
Unité Intégrité du Génome et Cancers, France
1.000000
0.02
Institut Paoli-Calmettes (IPC), France
1.000000
0.02
Institut du Cancer de Montpellier (ICM), France
1.000000
0.02
Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-Oncopole), France
1.000000
0.02
Centre Léon Bérard (CLB), France
1.000000
0.02
Centre Antoine-Lacassagne (CAL), France
1.000000
0.02
Tenon Hospital, France
1.000000
0.02
Institut Curie Hospital, France
1.000000
0.02
Centre Georges-François Leclerc (CGFL), France
1.000000
0.02
CHU Limoges, France
1.000000
0.02
Institute of Cancer Research (ICO), France
0.500000
0.01
Center for Research in Cancerology and Immunology Nantes-Angers (CRCINA), France
0.500000
0.01